This is a Validated Antibody Database (VAD) review about cow insulin like growth factor 1 receptor, based on 11 published articles (read how Labome selects the articles), using insulin like growth factor 1 receptor antibody in all methods. It is aimed to help Labome visitors find the most suited insulin like growth factor 1 receptor antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
insulin like growth factor 1 receptor synonym: IGFR1; insulin-like growth factor 1 receptor; IGF-I receptor; insulin-like growth factor I receptor; insulin-like growth factor receptor type 1

Cell Signaling Technology
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1a
Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling, 3021) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1a). Oncotarget (2017) ncbi
rabbit polyclonal
  • western blot; mouse; fig 3
Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling Tech, 3021) was used in western blot on mouse samples (fig 3). Drug Des Devel Ther (2015) ncbi
rabbit polyclonal
  • western blot; mouse; fig 3E
Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling Technology, 3021) was used in western blot on mouse samples (fig 3E). Sci Rep (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 4b
In order to learn the connections between sensitivity in a small-molecule dataset, Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling Technology, 3021) was used in western blot on human samples (fig 4b). Cancer Discov (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 1
Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling, 3021) was used in western blot on mouse samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1c,2a,2d,2f,2g,2i,2j,3a,3b,3c,3d,3e
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, Cell Signaling Technology insulin like growth factor 1 receptor antibody (CST, 3021) was used in western blot on human samples (fig 1c,2a,2d,2f,2g,2i,2j,3a,3b,3c,3d,3e). Mol Cancer (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to analyze NPM-ALK+ T-cell lymphoma and the transcription factors MZF1 and Ik-1 that downregulate IGF-IR expression, Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling Technology, 3021) was used in western blot on human samples (fig 3). Mol Cancer (2015) ncbi
rabbit polyclonal
  • western blot; mouse
In order to elucidate the factors that mediate radiation-induced endothelial dysfunction, Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cst, 3021) was used in western blot on mouse samples . J Proteome Res (2015) ncbi
rabbit polyclonal
  • western blot; human
In order to determine the effects of ASP3026treatment on NPM-ALK+ ALCL cell lines in vitro and on systemic lymphoma growth in vivo, Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling Technology, 3021) was used in western blot on human samples . Oncotarget (2014) ncbi
rabbit polyclonal
  • western blot; human
In order to evaluate a novel insulin/IGF signaling pathway inhibitor for its protective effect on age-onset, neurodegeneration-linked proteotoxicity, Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling Technology, 3021) was used in western blot on human samples . Aging Cell (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:500
Cell Signaling Technology insulin like growth factor 1 receptor antibody (Cell Signaling Technology, 3021) was used in immunohistochemistry - free floating section on mouse samples at 1:500. J Comp Neurol (2005) ncbi
Articles Reviewed
  1. Björner S, Rosendahl A, Simonsson M, Markkula A, Jirström K, Borgquist S, et al. Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatmen. Oncotarget. 2017;8:9093-9107 pubmed publisher
  2. Sun J, Fu X, Liu Y, Wang Y, Huo B, Guo Y, et al. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice. Drug Des Devel Ther. 2015;9:6327-42 pubmed publisher
  3. Ni Y, Nagashimada M, Zhuge F, Zhan L, Nagata N, Tsutsui A, et al. Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. Sci Rep. 2015;5:17192 pubmed publisher
  4. Seashore Ludlow B, Rees M, Cheah J, Cokol M, Price E, Coletti M, et al. Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset. Cancer Discov. 2015;5:1210-23 pubmed publisher
  5. Nemazanyy I, Montagnac G, Russell R, Morzyglod L, Burnol A, Guan K, et al. Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling. Nat Commun. 2015;6:8283 pubmed publisher
  6. Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 2015;14:113 pubmed publisher
  7. Vishwamitra D, Curry C, Alkan S, Song Y, Gallick G, Kaseb A, et al. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma. Mol Cancer. 2015;14:53 pubmed publisher
  8. Azimzadeh O, Sievert W, Sarioglu H, Merl Pham J, Yentrapalli R, Bakshi M, et al. Integrative proteomics and targeted transcriptomics analyses in cardiac endothelial cells unravel mechanisms of long-term radiation-induced vascular dysfunction. J Proteome Res. 2015;14:1203-19 pubmed publisher
  9. George S, Vishwamitra D, Manshouri R, Shi P, Amin H. The ALK inhibitor ASP3026 eradicates NPM-ALK? T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model. Oncotarget. 2014;5:5750-63 pubmed
  10. El Ami T, Moll L, Carvalhal Marques F, Volovik Y, Reuveni H, Cohen E. A novel inhibitor of the insulin/IGF signaling pathway protects from age-onset, neurodegeneration-linked proteotoxicity. Aging Cell. 2014;13:165-74 pubmed publisher
  11. Farrar C, Huang C, Clarke S, Houser C. Increased cell proliferation and granule cell number in the dentate gyrus of protein repair-deficient mice. J Comp Neurol. 2005;493:524-37 pubmed